NasdaqCM - Nasdaq Real Time Price USD
Regulus Therapeutics Inc. (RGLS)
2.3200
+0.3100
+(15.42%)
At close: 4:00:01 PM EDT
2.3400
+0.02
+(0.86%)
After hours: 6:09:42 PM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| AKER CHRISTOPHER RAY General Counsel | Sale | Jan 14, 2025 | 49,546 |
| BALTIMORE DAVID Director | Purchase | Jan 30, 2025 | 22,169 |
| CALSADA CRISPINA CPA Chief Financial Officer | Sale | Jan 14, 2025 | 45,478 |
| COLLIER KATHRYN J. Director | Purchase | Jul 25, 2024 | 6,740 |
| HAGAN JOSEPH PATRICK Chief Executive Officer | Purchase | Jan 30, 2025 | 260,808 |
| KLASSEN PRESTON S President | Sale | Jan 13, 2025 | 36,055 |
| PAPADOPOULOS STELIOS B Director | Stock Award(Grant) | Mar 14, 2024 | 978,388 |
Related Tickers
HURA TuHURA Biosciences, Inc.
4.0800
-2.86%
VTYX Ventyx Biosciences, Inc.
1.1800
+4.42%
GOSS Gossamer Bio, Inc.
0.8274
+1.77%
TVTX Travere Therapeutics, Inc.
15.88
+5.10%
TARA Protara Therapeutics, Inc.
3.9400
+2.34%
THTX Theratechnologies Inc.
2.7300
+7.06%
DAWN Day One Biopharmaceuticals, Inc.
7.33
+2.66%
NKTX Nkarta, Inc.
2.2200
+20.00%
MLTX MoonLake Immunotherapeutics
39.45
-1.37%
DYN Dyne Therapeutics, Inc.
9.91
+6.22%